Beijing Xinggu Lvsan Technology Co., Ltd. Formerly known as Beijing Lvsan Technology Co., Ltd.
Compliance Profile
"Due Diligence Flag: Beijing Xinggu Lvsan Technology Co., Ltd. Formerly known as Beijing Lvsan Technology Co., Ltd. has records on compliance watchlists (FDA WARNING LETTER). Review obligations before proceeding."
Banking Impact
Records on FDA WARNING LETTER can trigger enhanced due diligence, compliance holds, counterparty review and documentation requests from banks, investors or procurement teams.
Legal Status
The record should be reviewed against the original source list, jurisdiction and date of publication before decisions are made. Escalation may be required for procurement, onboarding or investor diligence.
Official Source Metadata
Source: FDA Warning Letters| Full Legal Name | Beijing Xinggu Lvsan Technology Co., Ltd. Formerly known as Beijing Lvsan Technology Co., Ltd. |
| Source Records | FDA WARNING LETTER |
| Enforcement Type | FDA Warning Letters |
| Identifiers | 2022-10-05 / CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/Misbranded |
| Risk Topics | reg.action, reg.warn, sector.medical |
| Official Source | View source record |
Compliance Context Review
Independent Risk Assessment
SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.